Can exposure to certain viruses lead to diabetes?
New York, Feb 20 : Scientists have identified four viruses that can produce insulin-like hormones that are active on human cells, thereby opening up possibilities of revealing biological mechanisms that may cause diabetes or cancer.
CMFRI to launch nutraceutical product to treat thyroid disorder
Kochi, Feb 14 : After having developed nutraceutical products to treat diabetes, arthritis, and cholesterol from marine organisms such as seaweeds and green mussel, the Central Marine Fisheries Research Institute (CMFRI) is all set to launch a natural product from the sea to tackle thyroid ...
Night shifts may raise risk of diabetes
New York, Feb 13 : Do you frequently work in night shifts? Beware, you are more likely to develop Type 2 diabetes, a precursor to cardiovascular diseases, researchers have warned.
Diabetes Care Foundation of India opens free camp for underprivileged ... New Delhi , Feb.12 : The Diabetes Care Foundation of India (DCFI), a non-profit organisation, working extensively on facing the challenge of diabetes, organised a free diabetes/hypertension related end-organ damage screening camp for underprivileged high-risk diabetes patients at a government ...
Covestro plastic enables medical device innovation ANAHEIM, Calif., Feb. 9: One of the fastest-growing segments in the pharmaceutical industry is biologic drugs. Derived from a microorganism, or plant or animal cells, biologics are often used to treat rheumatoid arthritis, cancer, diabetes and many other diseases.
Continuing the fight against diabetes on basketball courts across ... TORONTO, Feb. 8: Nothing but net for kids across Canada as Sun Life Financial Inc. (TSX: SLF) (NYSE: SLF), the Toronto Raptors and the NBA team up to expand the highly successful Sun Life Dunk for Diabetes program to 20 Boys and Girls Clubs within the regions of Vancouver, Kelowna, Calgary, ...
Chronic diseases raise cancer, mortality risk
New York, Feb 4 : Several common chronic diseases including hypertention, heart disease and diabetes, together account for more than a fifth of new cancer cases and more than a third of cancer deaths, finds a study.
JDRF Research Accomplishments Lead the Way to Prevent Future Type 1 ... NEW YORK, Jan.23: During the past year, JDRF, the world's largest private sector funder of type 1 diabetes (T1D) research, has driven breakthrough results and enabled research leading to significant advances in treatment options and a clearer understanding of a disease that affects 1.25 million ...
Slow down ageing with antioxidant-rich food
New Delhi, Jan 22 : Slow down ageing, reduce the risk of heart diseases and diabetes -- these are some reasons why it is important to consume antioxidant-rich foods like dark chocolates, nuts, kidney beans, cranberries and tomatoes, suggest experts.
Secret of longevity protein revealed! Washington D.C. , Jan. 17 : A team of researchers has discovered an anti-ageing protein, named after a Greek goddess, which may play an important role in the treatment of multiple diseases ranging from diabetes to cancers.
This anti-ageing protein may combat obesity, cancers
New York, Jan 18 : Scientists have revealed the three-dimensional (3D) structure of an anti-ageing protein, that may not only increase human lifespan but also help develop therapies for age-related diseases such as diabetes, obesity and cancers.
Breastfeeding halves diabetes risk in women Washington D.C. [U.S.A.], Jan 17 : Women who breastfeed their newborns for six months or longer significantly reduce their risk of developing diabetes by half as they get older, finds a recent study.
Intuity Medical Obtains USD 70M in Funding From Existing Investors ... FREMONT, Calif: Intuity Medical, Inc., a privately-held company developing innovative technologies for diabetes management, announced today that it has closed USD 42.5M in the initial tranche of a USD 70M total round of funding which includes USD 40M in equity financing from Intuity's existing ...
China FDA Approves New Once-Weekly Bydureon(R) to Improve Glycemic ... SHANGHAI: 3Sbio Inc. (01530.HK) announced today that China's first Glucagon-like peptide-1 (GLP-1) receptor agonist weekly preparation Bydureon (generic name Exenatide Microsphere for injection) has been formally approved by China Food and Drug Administration (CFDA), as a new treatment option to ...